 | Five Prime Therapeutics Inc (NASDAQ:FPRX) Short Interest Update
www.americanbankingnews.com - May 22 at 1:01 PM |
| Five Prime Therapeutics Inc (NASDAQ:FPRX) Major Shareholder Purchases $1,203,706.70 in Stock
www.americanbankingnews.com - May 18 at 9:52 PM |
| Wedbush Research Analysts Cut Earnings Estimates for Five Prime Therapeutics Inc (NASDAQ:FPRX)
www.americanbankingnews.com - May 18 at 1:30 AM |
| Five Prime Therapeutics Inc (NASDAQ:FPRX) Expected to Announce Quarterly Sales of $4.43 Million
www.americanbankingnews.com - May 17 at 1:34 AM |
| Zacks: Brokerages Anticipate Five Prime Therapeutics Inc (NASDAQ:FPRX) to Announce -$0.69 Earnings Per Share
www.americanbankingnews.com - May 15 at 10:23 PM |
 | Is Five Prime Therapeutics (FPRX) Stock a Solid Choice Right Now?
finance.yahoo.com - May 15 at 1:05 PM |
| Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Just Reported And Analysts Have Been Cutting Their Estimates
finance.yahoo.com - May 10 at 4:10 PM |
 | Five Prime Therapeutics, Inc. (FPRX) CEO Thomas Civik on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 12:54 AM |
| Edited Transcript of FPRX earnings conference call or presentation 7-May-20 8:30pm GMT
finance.yahoo.com - May 8 at 8:47 PM |
| Five Prime Therapeutics EPS beats by $0.11, beats on revenue
seekingalpha.com - May 8 at 2:58 AM |
|
| Five Prime Therapeutics Inc (NASDAQ:FPRX) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 7 at 6:16 PM |
| Five Prime Therapeutics Reports First Quarter 2020 Results
finance.yahoo.com - May 7 at 4:57 PM |
| Five Prime Therapeutics Inc (NASDAQ:FPRX) Short Interest Up 9.4% in April
www.americanbankingnews.com - May 2 at 2:01 PM |
| Five Prime Therapeutics (FPRX) Set to Announce Earnings on Thursday
www.americanbankingnews.com - May 1 at 3:51 PM |
| Five Prime Therapeutics Announces Timing of Its First Quarter 2020 Results Conference Call
finance.yahoo.com - April 30 at 6:50 PM |
 | FPRX Five Prime Therapeutics, Inc. Common Stock
www.nasdaq.com - April 25 at 7:23 PM |
| Five Prime Therapeutics Changes 2020 Annual Meeting to Virtual Format
finance.yahoo.com - April 22 at 7:33 PM |
| Five Prime Therapeutics names new CEO
seekingalpha.com - April 14 at 1:49 PM |
| Five Prime Therapeutics Appoints Tom Civik as Chief Executive Officer
finance.yahoo.com - April 14 at 1:49 PM |
| Here's Why Five Prime Therapeutics (NASDAQ:FPRX) Must Use Its Cash Wisely
finance.yahoo.com - April 9 at 8:42 AM |
| Edited Transcript of FPRX earnings conference call or presentation 27-Feb-20 9:30pm GMT
finance.yahoo.com - March 18 at 6:54 PM |
 | Five Prime Therapeutics Announces Publication of the Phase 1 Bemarituzumab Study in the Journal of Clinical Oncology
www.businesswire.com - March 13 at 9:50 AM |
| Five Prime Therapeutics, Inc. (FPRX) CEO William Ringo on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 10:58 PM |
| Five Prime Therapeutics (FPRX) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - February 27 at 10:58 PM |
| Five Prime Therapeutics Reports Fourth Quarter and Full Year 2019 Results
www.businesswire.com - February 27 at 5:57 PM |
| Five Prime Therapeutics EPS beats by $0.07, misses on revenue
seekingalpha.com - February 27 at 5:57 PM |
| Five Prime Therapeutics (FPRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - February 20 at 5:31 PM |
 | BRIEF-Five Prime Therapeutics Licenses Antibodies To Seattle Genetics For Use In Novel Antibody Drug Conjugate Programs
www.msn.com - February 19 at 2:40 PM |
| Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs
finance.yahoo.com - February 19 at 2:40 PM |
| Five Prime down 4% on failed cabiralizumab study
seekingalpha.com - February 18 at 1:24 PM |
| Five Prime Therapeutics: Management Shakeup, Activist Investor, Valued At Cash, Ripe For A Turnaround In 2020
seekingalpha.com - February 18 at 1:24 PM |
| Five Prime Therapeutics Provides Update on Phase 2 Trial of Cabiralizumab Combined with Opdivo ® in Pancreatic Cancer
www.businesswire.com - February 18 at 1:24 PM |
| Five Prime Therapeutics Provides Update on Phase 2 Trial of Cabiralizumab Combined with Opdivo® in Pancreatic Cancer
finance.yahoo.com - February 18 at 1:24 PM |
| Five Prime Therapeutics Announces Timing of Its Fourth Quarter and Full Year 2019 Results Conference Call
finance.yahoo.com - February 13 at 7:56 PM |
| Five Prime Therapeutics (FPRX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 17 at 1:41 PM |
| An Activist Fund Has Been Buying Five Prime Pharma
seekingalpha.com - January 17 at 8:41 AM |
| Five Prime Therapeutics: An Activist Fund Owns 22% Of This Biotech
seekingalpha.com - January 16 at 1:23 PM |
| If You Had Bought Five Prime Therapeutics (NASDAQ:FPRX) Stock Three Years Ago, You'd Be Sitting On A 89% Loss, Today
finance.yahoo.com - January 10 at 5:00 PM |
| If You Had Bought Five Prime Therapeutics (NASDAQ:FPRX) Stock Three Years Ago, You'd Be Sitting On A 89% Loss, Today
finance.yahoo.com - January 10 at 5:00 PM |
| Five Prime Therapeutics to Participate in the 38th Annual J.P. Morgan Healthcare Conference
www.businesswire.com - December 30 at 1:13 PM |
| Five Prime Therapeutics Announces Resignation of Dr. Lewis T. "Rusty" Williams From Board of Directors
finance.yahoo.com - December 27 at 6:08 PM |
| Five Prime founder leaves board to focus on startup
seekingalpha.com - December 26 at 8:37 PM |
| Five Prime Therapeutics Announces Resignation of Dr. Lewis T. “Rusty” Williams From Board of Directors
www.businesswire.com - December 26 at 8:37 PM |
| Five Prime Therapeutics Announces Resignation of Dr. Lewis T. "Rusty" Williams From Board of Directors
finance.yahoo.com - December 26 at 8:37 PM |
| Head of big South San Francisco biotech thriving in first CEO role
finance.yahoo.com - December 20 at 6:34 PM |
| Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy ?
finance.yahoo.com - December 10 at 2:41 PM |
| Our Take On Five Prime Therapeutics
seekingalpha.com - November 18 at 3:59 PM |
| Edited Transcript of FPRX earnings conference call or presentation 6-Nov-19 9:30pm GMT
finance.yahoo.com - November 12 at 1:19 PM |
| Five Prime Therapeutics Presents Initial Safety Data from the Phase 1 Trial of FPT155 at the Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - November 9 at 10:28 AM |
| Five Prime Therapeutics, Inc. (FPRX) CEO William Ringo on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 11:51 PM |
